Skip to content
MarketScale
‹ Back to Industries

Sciences

Phononic + MarketScale Recap

Phononic, a solid-state cooling and heating solutions provider, has partnered with MarketScale to produce video content that showcases its technology. The collaboration leverages MarketScale's video production and community-generated content capabilities to engage and educate audiences about Phononic's innovations. Together, the two companies aim to tell compelling visual stories around Phononic's products and market impact.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

Promoted content from Phononic on MarketScale.

By Sciences ·
Share

Key takeaways

01

Phononic specializes in solid-state cooling and heating technology and partnered with MarketScale for content production.

02

The partnership focuses on video storytelling to educate and engage target audiences about Phononic's solutions.

03

MarketScale provides video production and community-generated content expertise to amplify Phononic's brand presence.

Phononic, a leading provider of solid-state cooling and heating solutions, has formed a dynamic partnership with MarketScale, a renowned video production and community-generated content creation company. This collaboration brings together Phononic’s expertise in innovative technology and MarketScale’s prowess in visual storytelling, resulting in captivating video content that engages and educates audiences.

Through their partnership, Phononic and MarketScale combine their strengths to produce high-quality videos that showcase the transformative power of solid-state cooling and heating solutions across various industries. MarketScale’s talented team of videographers and content creators work closely with Phononic to craft compelling narratives that highlight the benefits, applications, and real-world impact of Phononic’s technology.

By leveraging MarketScale’s community-generated content creation capabilities, the partnership enables Phononic to gather valuable insights, experiences, and testimonials from users and industry experts. This collaborative approach ensures that the content resonates with the target audience and offers valuable perspectives on the practical applications of Phononic’s solutions.

Together, Phononic and MarketScale create visually stunning videos that not only showcase the technical aspects of solid-state cooling and heating but also demonstrate the positive outcomes it delivers in industries such as healthcare, life sciences, and food and beverage. The partnership’s emphasis on storytelling and community-generated content allows viewers to connect with the technology on a deeper level, fostering understanding and inspiring innovation.

Phononic’s collaboration with MarketScale as their video production and community-generated content creation partner reinforces their commitment to delivering impactful and engaging content. Through their combined expertise, they empower audiences to discover the immense potential and transformative capabilities of solid-state cooling and heating solutions.

Phononic

Part of this channel

Phononic

Solid-state cooling without compressors, refrigerants, or trade-offs.

Visit the channel →

About the author

S
Sciences

New to MarketScale?

MarketScale is the platform Sciences companies use to turn their own experts into content like this. Want the short overview?

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I clinical study of an oral solid dose formulation designed using AI, cleared by the UK's MHRA and conducted at the company's UK facility. The trial—built on machine learning algorithms from partner Intrepid Labs and Quotient's Translational Pharmaceutics platform—aims to validate AI as a direct contributor to formulation design rather than just an upstream analytical tool. Benchling characterizes the broader moment as biotech entering a "builder phase," in which leading organizations embed AI capability at the bench level rather than running isolated pilots.

  • 01Quotient Sciences has dosed healthy volunteers in a Phase I study it describes as the first clinical evaluation of an AI-designed oral formulation, following approval from the UK's MHRA.
  • 02The formulation was developed using advanced machine learning algorithms from Intrepid Labs, integrated with Quotient Sciences' Translational Pharmaceutics platform.
  • 03Benchling identifies a sector-wide shift toward embedding AI capability directly at the bench, moving beyond isolated pilots to structural adoption across biotech R&D.

Jun 17, 2026

Tekniplex Showcases Sustainable Materials Innovation at Paris Packaging Week 2026

Tekniplex Showcases Sustainable Materials Innovation at Paris Packaging Week 2026

At Paris Packaging Week 2026, Tekniplex showcased its latest sustainable materials innovations, emphasizing the intersection of materials science and brand storytelling. The company's booth featured a living wall and digital displays to engage a sustainability-conscious audience, highlighting advanced materials for sustainability and product performance in cosmetics packaging.

  • 01Tekniplex emphasized sustainable materials innovation at Paris Packaging Week 2026.
  • 02The company's booth featured eco-friendly design elements and immersive digital displays.
  • 03Tekniplex highlighted advancements in recyclable sealing systems and materials for cosmetics.

Apr 9, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences